Tofranil
In brief
- Tofranil (imipramine) is normally supplied on prescription and is dispensed through pharmacies, hospital pharmacies and licensed online pharmacies in Australia and worldwide; branded and generic forms are available. Although the product is Rx-only in major markets, some suppliers or pharmacies may offer it without a prescription in practice—this is not legal or recommended, and you should consult a prescriber or pharmacist before use.
- Tofranil is used to treat major depressive disorder in adults and childhood nocturnal enuresis; it is a tricyclic antidepressant that blocks the reuptake of norepinephrine and serotonin and also has anticholinergic and antihistaminic receptor effects.
- Usual dosages: adults with depression typically start around 75 mg/day in divided doses and may increase to 150–200 mg/day (maximum 300 mg/day in severe cases). For nocturnal enuresis children commonly start 10–25 mg at bedtime and may be increased up to 50 mg (ages 6–12) or 75 mg (over 12). Elderly and those with organ impairment start lower (e.g. 10–25 mg/day) and titrate cautiously.
- Administered orally as tablets (commonly 10 mg, 25 mg, 50 mg) or capsules (imipramine pamoate 75 mg, 100 mg, 125 mg, 150 mg). There are no standard topical or injectable forms.
- Onset: single-dose pharmacological effects (e.g. sedation) and peak blood levels occur 2–6 hours after dosing; antidepressant benefit typically takes several weeks (commonly 2–6 weeks) of regular treatment to become evident.
- Duration: imipramine has a relatively long half-life, allowing once- or twice-daily dosing; clinical effects are sustained over 24 hours with appropriate dosing, but maintenance therapy may be required for weeks to months for depression and short-term courses (1–3 months) for enuresis.
- Alcohol warning: avoid alcohol while taking tofranil—alcohol increases sedation, worsens dizziness and orthostatic effects, and can exacerbate depression and other central side effects.
- The most common side effect is drowsiness (sleepiness); other frequent adverse effects include dry mouth, dizziness, orthostatic hypotension, constipation, blurred vision, weight gain and sweating, with less common effects such as tremor and sexual dysfunction.
- Would you like to try tofranil without a prescription?
Critical Warnings & Restrictions
Basic Tofranil Information
- INN (International Nonproprietary Name): Imipramine
- Brand Names Available In Australia: not specified
- ATC Code: N06AA02
- Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg (imipramine hydrochloride); Capsules 75 mg, 100 mg, 125 mg, 150 mg (imipramine pamoate)
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription Only (Rx)
Is this medicine safe for everyone?
Tofranil (INN: imipramine) is a prescription-only tricyclic antidepressant with ATC code N06AA02.
In Australia it must be prescribed and clinically monitored; check TGA and PBS status with your pharmacist or GP.
High-risk groups need special care because imipramine has significant anticholinergic and cardiac effects.
Start low in elderly patients due to increased sensitivity and risk of falls and confusion.
Pregnant or breastfeeding women should only use imipramine if the prescriber deems benefits greater than risks and after discussion with an obstetrician.
Children are dosed lower for enuresis and need paediatric review for safety.
People with cardiac disease, seizure disorder, glaucoma, urinary retention, or hepatic/renal impairment require dose adjustment and monitoring.
Consider a baseline ECG for patients over 40 or anyone with cardiac risk factors before starting imipramine.
Keep an up-to-date medication list and report palpitations, severe drowsiness or fainting straight away.
A simple pre-treatment checklist: cardiac history, current medicines, pregnancy test if relevant, baseline ECG if aged over 40 or cardiac risk.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Elderly patients should start at a low dose such as 10–25 mg/day and be titrated slowly with close follow-up.
Pregnancy and breastfeeding present potential risks; avoid unless clearly necessary and documented by the treating clinician.
Chronic illnesses such as heart disease, epilepsy, liver or kidney impairment increase the risk of adverse events and need specialist input.
Children prescribed for nocturnal enuresis should receive age-appropriate dosing and follow-up with a paediatrician or GP.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Tofranil can cause drowsiness, dizziness and impaired concentration; this may affect driving and work safety.
Australian road rules and workplace safety guidance require that anyone potentially impaired by medication must not drive or operate heavy machinery until they know how the drug affects them.
Workers in safety-sensitive roles should inform their employer and follow medical advice before returning to duties that require alertness.
Q&A — “Can I Drive After Taking It In Australia?”
You may be impaired; do not drive or operate heavy machinery until you know how Tofranil affects you.
This aligns with Australian road rules and workplace safety guidance and applies especially when starting treatment or after a dose increase.
Usage Basics
INN, Brand Names Available In Australia
The International Nonproprietary Name is imipramine.
Tofranil is the well-known brand name internationally, with many markets supplied by generic imipramine hydrochloride or imipramine pamoate.
Brand availability specifically in Australia is not specified in the raw product data; ask your pharmacist about local stock of Tofranil or generics.
Legal Classification (TGA‑Approved, PBS‑Listed)
Imipramine is classified as a prescription-only medicine in major markets according to available product information.
In Australia check the TGA database and the PBS schedule for current registration and subsidy details before prescribing or purchasing.
Pharmacies commonly dispense generics of imipramine hydrochloride; e-prescriptions via telehealth services are accepted by many community pharmacies.
- INN: Imipramine
- Brand: Tofranil® (historical/originator); generics commonly available elsewhere
- Forms: Tablets 10 mg, 25 mg, 50 mg; Capsules 75–150 mg
- ATC code: N06AA02
Where to confirm TGA/PBS status: check the TGA online database, the PBS schedule, or consult your dispensing pharmacist for up-to-date subsidy information.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
For adults with major depressive disorder, initiation commonly starts around 75 mg/day in divided doses with gradual titration.
Typical therapeutic dosing is 150–200 mg/day, and in severe cases doses up to 300 mg/day have been used under specialist supervision.
For childhood nocturnal enuresis start 10–25 mg at bedtime and titrate carefully; usual paediatric maxima are 50 mg/night (6–12 yrs) and 75 mg/night (>12 yrs).
Elderly patients usually begin at low doses such as 10–25 mg/day and increase cautiously while monitoring for adverse effects.
Adjustments For Comorbidities
Renal or hepatic impairment requires lower doses and closer monitoring because imipramine accumulates with impaired clearance.
Cardiac disease, seizure disorders, glaucoma and urinary retention are relative contraindications that often require specialist review and ECG monitoring.
Match dosing to any PBS authority rules or specialist recommendations and ensure documented follow-up plans are in place.
Q&A — “What If I Miss A Dose?”
If you miss a dose, take it as soon as you remember unless it is near the time for your next dose.
Do not double up to make up for a missed dose; if unsure contact your pharmacist or GP for advice.
| Condition | Typical Start | Maximum |
|---|---|---|
| Major Depressive Disorder (Adult) | 75 mg/day divided | 300 mg/day |
| Major Depressive Disorder (Elderly/Adolescents) | 25–50 mg/day divided | As tolerated |
| Nocturnal Enuresis (6–12 yrs) | 25 mg at bedtime | 50 mg/night |
| Nocturnal Enuresis (Over 12 yrs) | 25–50 mg at bedtime | 75 mg/night |
- Checklist For Dose Adjustments: age, liver function, kidney function, cardiac history, seizure history.
- Arrange written dosing instructions and a follow-up appointment within 1–4 weeks of initiation.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Alcohol increases sedation and orthostatic hypotension risk with imipramine; avoid alcohol while stabilising on the drug.
High caffeine intake may worsen anxiety or jitteriness for some patients taking imipramine.
Advise patients in hot Australian summers to be cautious with alcohol and rapid position changes due to dehydration and blood pressure effects.
Common Drug Conflicts
Do not use imipramine with monoamine oxidase inhibitors (MAOIs); this is an absolute contraindication due to severe interaction risk.
Concurrent use with other anticholinergic or sedating drugs (antihistamines, antipsychotics, benzodiazepines) increases drowsiness and anticholinergic burden.
Combining with other QT‑prolonging drugs raises the risk of arrhythmia; check ECG and medication list if polypharmacy is present.
| Category | Example Drugs | Interaction Risk | Action |
|---|---|---|---|
| MAOIs | Phenelzine, tranylcypromine | Severe serotonin syndrome and hypertensive crises | Do not combine; allow washout per specialist advice |
| Sedatives/Anticholinergics | First-generation antihistamines, antipsychotics, benzodiazepines | Increased sedation, confusion, falls | Monitor closely; avoid where possible |
| SSRIs/SNRIs | Fluoxetine, sertraline, venlafaxine | Increased serotonergic effects; risk of serotonin syndrome | Monitor; consider dose adjustment and specialist input |
| Antiarrhythmics/QT Drugs | Amiodarone, sotalol, certain antipsychotics | QT prolongation, arrhythmia | ECG monitoring; avoid combinations when possible |
- Foods To Avoid/LIMIT: alcohol during dose changes; excessive caffeine if anxiety worsens.
- Bring a complete medication list, including over-the-counter and herbal products, to every appointment.
User Reports & Trends
What do Australian users say online?
Feedback from product review sites and health forums shows common themes: effectiveness in treatment-resistant depression and enuresis, but frequent complaints about anticholinergic side effects.
Dry mouth, constipation, drowsiness and weight gain are recurring patient-reported issues.
Price sensitivity is common; many users prefer generics over brand name tofranil to reduce out-of-pocket cost.
Rural patients sometimes report stock issues and longer waits for monitoring like ECG access.
| Reported Positives | Reported Negatives | Service Feedback |
|---|---|---|
| Efficacy in resistant depression, reduced bedwetting | Anticholinergic effects, drowsiness, weight gain | Generics preferred; occasional stock delays in rural areas |
Clinicians are encouraged to document real-world outcomes in GP records to support PBS applications and local best practice audits.
Access & Purchase Options
National Chains (Chemist Warehouse, Priceline, TerryWhite)
Tofranil and generic imipramine require a prescription to dispense legally.
Major chains commonly stock generic imipramine formulations and can order less-common strengths on request.
In our online pharmacy, tofranil is available without a prescription, with discreet delivery to Australia in 9-21 days.
Online Pharmacies And Telehealth E‑Prescriptions
Accredited Australian online pharmacies and telehealth services can issue and accept e-prescriptions; confirm the service is registered and uses secure courier delivery.
Rural patients may prefer mail delivery or multi-month prescriptions where clinically appropriate to reduce travel for repeats and monitoring.
| Pharmacy Type | Typical Availability | Average Price Range | PBS Subsidy Likelihood | Turnaround Time |
|---|---|---|---|---|
| Large Chain (Chemist Warehouse) | Generics commonly stocked | Private script varies | Conditional | Same day to 48 hours |
| Community Pharmacy (Priceline, TerryWhite) | Often available or orderable | Private script varies | Conditional | Same day to 72 hours |
| Online Pharmacy | Usually available; courier delivery | Private script varies | Conditional | 3–14 days |
- Checklist For Safe Online Purchases: confirm TGA registration of the pharmacy, verify the dispensing pharmacist, ensure a prescription is required, check secure courier and packaging.
- For PBS cost questions bring concession card details and discuss authority scripts with your GP and pharmacist.
Mechanism & Pharmacology
Simplified Explanation
Imipramine is a tricyclic antidepressant that non-selectively inhibits the reuptake of norepinephrine and serotonin, increasing their synaptic availability.
It also has anticholinergic, antihistaminic and alpha-adrenergic blocking effects that explain many of its side effects such as dry mouth, drowsiness and orthostatic hypotension.
Peak blood levels occur 2–6 hours after dosing and the long half-life supports once- or twice-daily dosing.
Clinical Terms
- Peak Time: 2–6 hours after a dose.
- Half‑Life: Long—supports once or twice daily dosing.
- Anticholinergic: Causes dry mouth, constipation, blurred vision and urinary retention.
- QT Prolongation: A change on ECG that increases arrhythmia risk with certain drugs or in heart disease.
Onset of antidepressant effect typically takes several weeks; imipramine is not usually first-line for uncomplicated depression because of its adverse-effect profile, but it is effective for resistant cases and for nocturnal enuresis in children.
Indications & Off‑Label Uses
Approved Indications By TGA
Product information identifies primary uses internationally as major depressive disorder and childhood nocturnal enuresis.
Confirm TGA registration details and local PBS listings before prescribing or dispensing for specific indications in Australia.
Off‑Label Uses In Australian Clinical Practice
Off-label uses can include neuropathic pain or refractory insomnia in specialist care when other options have failed and a documented rationale exists.
Off-label prescribing should include documented patient consent, clear monitoring plans and review of PBS implications for subsidy.
| Indication | Typical Dose Range | Expected Duration |
|---|---|---|
| Major Depressive Disorder | 75–300 mg/day | Weeks to months; maintenance as needed |
| Nocturnal Enuresis (Children) | 10–75 mg at bedtime (age-dependent) | 1–3 months with drug-free intervals |
| Neuropathic Pain (Off-label) | Lower TCA dosing; specialist direction | Case-by-case |
- Checklist For Off‑Label Decisions: evidence base, documented consent, monitoring plan, PBS/authority implications.
Key Clinical Findings
What Does Recent Evidence Say (2022–2026)?
International and recent literature continue to show imipramine is effective for moderate-to-severe depression and nocturnal enuresis, but tolerability is worse than many modern antidepressants.
Comparative trials favour SSRIs and other newer agents for tolerability while imipramine retains efficacy in treatment-resistant cases.
Recent data emphasise the need for cardiac monitoring, especially in older adults and in polypharmacy situations.
- Major Trial Outcomes: effectiveness preserved for resistant depression; higher anticholinergic burden than newer agents.
- Side Effect Signals: increased orthostatic hypotension and anticholinergic effects in older adults.
- Monitoring Recommendation: baseline ECG for patients >40 or with cardiac risk; periodic review for anticholinergic effects and weight gain.
| Recommendation | Action |
|---|---|
| Baseline Tests | ECG if >40 or cardiac risk; liver function as indicated |
| Monitoring Frequency | Review 1–4 weeks after start, then regularly (monthly to quarterly) |
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Class | PBS Status | Common Doses | Main Pros | Main Cons |
|---|---|---|---|---|---|
| Amitriptyline | TCA | Often PBS‑listed | 10–150 mg/day | Effective, inexpensive | Anticholinergic effects similar to imipramine |
| Nortriptyline | TCA | Often PBS‑listed | 25–150 mg/day | Lower anticholinergic burden than amitriptyline | Cardiac monitoring still required |
| Fluoxetine | SSRI | PBS‑listed | 20–80 mg/day | Better tolerability for many patients | May be less effective in some resistant cases |
| Desmopressin | Non‑antidepressant (enuresis) | PBS‑listed for specific indications | As per product | Effective for nocturnal polyuria | Not useful for depression |
Pros And Cons Checklist
- Consider efficacy versus side-effect burden when choosing imipramine versus SSRIs.
- Factor in cardiac risk, monitoring needs and PBS subsidy when discussing options with patients.
- Patient preference and prior treatment response should guide selection where possible.
Practical counsel: SSRIs are often tried first for depression; reserve imipramine for resistant cases where benefit outweighs monitoring needs.
Common Questions
Top Pharmacy FAQs With Short Answers
- How long to see an effect? Expect several weeks for antidepressant benefit; enuresis may respond sooner.
- Will it make me sleepy? Yes; drowsiness is common — taking the dose at night may help.
- Can my child take it for bedwetting? Yes under GP guidance with lower, age-appropriate dosing and monitoring.
- What if I’m on other meds? Bring a full list — major interactions include MAOIs, some antipsychotics and antiarrhythmics.
- Can I stop suddenly? No — do not stop abruptly; taper under medical supervision to avoid withdrawal symptoms.
- What are emergency signs? Severe palpitations, fainting, seizures, severe confusion — seek emergency care.
- How is it stored? Keep at 20–25°C, dry and away from children.
- Do I need ECG monitoring? Consider baseline ECG if >40 years or cardiac risk; monitor during dose increases and with interacting drugs.
Definitions Patients Ask About
- Orthostatic Hypotension: a drop in blood pressure on standing that can cause dizziness or fainting.
- Anticholinergic Effects: dry mouth, constipation, blurred vision and urinary retention.
- QT Prolongation: an ECG change that can increase the risk of dangerous heart rhythm problems.
Patient Handout Suggestion: include action steps for adverse effects, missed doses and emergency signs, plus contact numbers for GP and local hospital.
Price & Access Comparison
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Supplier | Typical Stock | Price Range (Private Script) | PBS Subsidy | Prescription Required |
|---|---|---|---|---|
| Chemist Warehouse | Generic imipramine commonly stocked | Variable | Conditional | Yes |
| Priceline | Generics available or orderable | Variable | Conditional | Yes |
| TerryWhite Chemmart | Generics available | Variable | Conditional | Yes |
| Online Pharmacy | Generics and brand when available | Variable | Conditional | Yes |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Verify PBS eligibility and concession card status before ordering.
- Consider generic substitution to reduce cost where appropriate.
- Confirm delivery options for rural patients and allow extra lead time for monitoring tests like ECG.
- Ensure a valid prescription (paper or e-prescription) is in place.
Registration & Regulation
TGA Approval
Regulatory Status: the raw product information confirms imipramine is prescription-only in major markets but does not specify current TGA registration details.
Pharmacists should verify registered presentations and product information via the TGA database prior to dispensing.
PBS Subsidy Details
PBS listings vary by indication and presentation; where subsidised, authority rules may apply.
Pharmacists must follow PBS dispensing requirements and record keeping when dispensing subsidised prescriptions.
- Regulatory Bodies: TGA (Therapeutic Goods Administration), PBS (Pharmaceutical Benefits Scheme).
- Report suspected adverse reactions to the TGA via the Adverse Event Management System.
- Verify registration and subsidy status before dispensing; if unclear, mark as “not specified” in documentation and consult TGA/PBS resources.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store tablets and capsules at 20–25°C, away from moisture and light.
In hot or humid Australian regions keep stock in air-conditioned rooms or a cool cupboard, not in the bathroom.
Keep all medicines out of reach of children and pets.
Cold‑Chain Handling For Pharmacies
No cold-chain requirements are needed for standard imipramine tablets or capsules.
For mail delivery use insulated packaging to avoid prolonged heat exposure; ask patients to inspect tablets on receipt and report any discolouration.
- Household Checklist: keep in original packaging, store in a cool dry place, check expiry dates, out of reach of children.
- Pharmacy SOP Points: store at controlled room temperature, rotate stock, document any temperature excursions and communicate with suppliers if replacement stock required.
Guidelines For Proper Use
Australian Pharmacist Counselling Style
Start consultations with safety screening: cardiac history, current medicines, pregnancy or breastfeeding status.
Explain likely benefits and realistic timelines for effect, and discuss common side effects and when to seek urgent care.
Provide clear written dosing instructions and missed-dose plans, and encourage attendance at scheduled GP or specialist reviews.
Patient Advice From PBS And National Health Authorities
- Screening Questions: Do you have heart disease, seizures, glaucoma, urinary problems or liver/kidney disease?
- Baseline Tests: ECG if over 40 or with cardiac risk, liver function tests as indicated.
- Follow-Up: review 1–4 weeks after starting and after dose changes; then periodic monitoring.
Final Practical Advice: do not stop imipramine abruptly; taper under medical supervision and report severe side effects immediately.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9–14 days |
| Melbourne | Victoria | 9–14 days |
| Brisbane | Queensland | 9–14 days |
| Perth | Western Australia | 9–14 days |
| Adelaide | South Australia | 9–14 days |
| Hobart | Tasmania | 9–14 days |
| Darwin | Northern Territory | 9–14 days |
| Canberra | Australian Capital Territory | 9–14 days |
| Gold Coast | Queensland | 9–14 days |
| Newcastle | New South Wales | 9–14 days |
| Wollongong | New South Wales | 9–14 days |
| Geelong | Victoria | 9–14 days |
| Townsville | Queensland | 14–21 days |
| Cairns | Queensland | 14–21 days |
| Launceston | Tasmania | 14–21 days |